Source: Eur Respir J 2011; 38: 1382-1392
Disease area: Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
Pimpin L., Drumright L.N., Kruijshaar M.E., Abubakar I., Rice B., Delpech V., Hollo V., Amato-Gauci A., Manissero D., Ködmön C.. Tuberculosis and HIV co-infection in European Union and European Economic Area countries. Eur Respir J 2011; 38: 1382-1392

Member's Comments

No comment yet.

Related content which might interest you: Tuberculosis and HIV co-infection: do we have a surveillance system in Europe? Source: Eur Respir J 2011; 38: 1258-1260 Year: 2011 Comparison of tuberculosis surveillance systems in low-incidence industrialised countries Source: Eur Respir J 2008; 32: 1616-1624 Year: 2008 TB and MDR/XDR-TB in European Union and European Economic Area countries: managed or mismanaged? Source: Eur Respir J 2012; 39: 619-625 Year: 2012 The burden of TB–HIV in the EU: how much do we know? A survey of surveillance practices and results Source: Eur Respir J 2011; 38: 1374-1381 Year: 2011 Risk factors for death among tuberculosis cases: analysis of European surveillance data Source: Eur Respir J 2008; 31: 1256-1260 Year: 2008 Drug-resistant tuberculosis in the European Union and European economic area Source: International Congress 2015 – The emergence of drug-resistant tuberculosis in Europe: no cure possible? Year: 2015 HIV screening in tuberculosis patients, in the northern region of Portugal Source: International Congress 2015 – Screening strategies in TB Year: 2015 Prevalence of latent tuberculosis infection among household contacts and community controls in South India Source: Annual Congress 2013 –Tuberculosis and latent tuberculosis infection: diagnosis and treatment Year: 2013 Tuberculosis in the European Union and European Economic Area: a survey of national tuberculosis programmes Source: Eur Respir J, 52 (6) 1801449; 10.1183/13993003.01449-2018 Year: 2018 Drug resistance among tuberculosis cases in the European Union and European Economic Area, 2007 to 2012 Source: International Congress 2014 – Tuberculosis: public health and primary prevention Year: 2014 Tuberculosis screening in migrants in selected European countries shows wide disparities Source: Eur Respir J 2006; 27: 801-807 Year: 2006 Rifampicin-resistant tuberculosis (RR-TB) in eastern Europe Source: International Congress 2016 – Rifampicin resistance, MDRTB, and new drug treatments Year: 2016 Tuberculosis treatment outcomes in HIV co-infected patients in Novokuznetsk, Russian Federation Source: International Congress 2018 – Tuberculosis comorbidities Year: 2018 The impact of immunodeficiency diseases on tuberculosis infection in North East of Romania Source: International Congress 2014 – Respiratory infections in children Year: 2014 The incidence of MDR-TB in new and retreatment cases of HIV and pulmonary tuberculosis co-infection Source: Annual Congress 2013 –Tuberculosis: clinical aspects Year: 2013 The risk of default in TB patients in the Russian Federation Source: International Congress 2014 – Mycobacterium tuberculosis infection and disease: clinical epidemiology 2 Year: 2014 Geographic origin and other determinants of site of tuberculosis disease in European countries Source: International Congress 2014 – Tuberculosis epidemiology: novel features Year: 2014 Trend in TB control in Republic of Moldova: High MDRTB burden country Source: International Congress 2014 – Tuberculosis: epidemiology and public health Year: 2014 Screening immigrants to Ireland from countries with a high prevalence of tuberculosis would be clinically beneficial and cost effective Source: Annual Congress 2013 –Tuberculosis and latent tuberculosis infection in subpopulations Year: 2013 Increased incidence of TB disease within the health-care workers in an intermediate TB burden country Source: International Congress 2014 – Tuberculosis: epidemiology and public health Year: 2014